Skip to main content
Clinical Trials/CTRI/2022/08/045084
CTRI/2022/08/045084Not yet recruiting未知

HIP fracture Accelerated surgical TreaTment And Care tracK 2 Trial - HIP ATTACK-2

Population Health Research Institute0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • 1) age =45 years;
  • 2) diagnosis of hip fracture during working hours with a low-energy mechanism requiring surgery;
  • 3) troponin elevation on hospital arrival (at least one troponin level from hip fracture occurrence to randomization above the upper limit of normal); and
  • 4) written informed consent.

Exclusion Criteria

  • 1) taking a therapeutic dose of an anticoagulant for which no reversing agent is available;
  • 2) patients on a therapeutic vitamin K antagonist with a history of heparin induced thrombocytopenia (HIT);
  • 3) patients with peri-prosthetic fracture, open fracture or bilateral fractures;
  • 4) patients requiring an emergency surgery for another reason (e.g., subdural hematoma);
  • 5) patients with acute myocardial infarction with a mechanical complication (i.e., acute papillary muscle rupture, ventricular septal defect), ST elevation myocardial infarction, or cardiogenic shock;
  • 6) patients refusing consent; or
  • 7) patients previously enrolled in HIP ATTACK-2.

Investigators

Similar Trials